Discover trends, market shifts, and competitive outlooks for the prenatal testing & newborn screening industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Has the Prenatal Testing & Newborn Screening Market Growth Performance Trended Historically, And What Lies Ahead?
The size of the prenatal testing & newborn screening market has seen significant expansion in recent years, increasing from $6.24 billion in 2024 to an estimated $6.99 billion in 2025, which represents a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the historical period include developments in genetic testing, a rise in maternal age, heightened awareness and education, as well as healthcare policy and regulations.
In the coming years, a substantial proportion of growth is anticipated in the prenatal testing & newborn screening market. The market size is projected to reach $11.08 billion in 2029, escalating at a compound annual growth rate (CAGR) of 12.2%. Factors contributing to the prospective growth during this forecast period include genetic counseling, technological innovations, point-of-care testing, telehealth, and remote monitoring. Major forecasting period trends comprise non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, as well as hemoglobinopathies and sickle cell screening.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Prenatal Testing & Newborn Screening Market?
The surge in genetic diseases among newborns has served as a catalyst for the expansion of the prenatal testing and newborn screening market. Genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease are states named by the World Health Organization. Sickle cell anemia is a sizable genetic disease that impacts countless individuals globally and is particularly widespread amongthose with ancestorship to Africa, America, Cuba, Central America, Saudi Arabia, and India. For example, a research led by the Rady Children’s Institute for Genomic Medicine in the US at the Rady Children’s Hospital in February 2023 revealed that 41% of infant fatalities resulted from single-locus (Mendelian) genetic diseases. This rise in the prevalence of genetic diseases among infants has increased the need for the prenatal testing and newborn screening market to grow.
Which Key Market Segments Comprise the Prenatal Testing & Newborn Screening Market and Drive Its Revenue Growth?
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp
Which Areas Are Leading Regions in the Prenatal Testing & Newborn Screening Market Expansion Across the Globe?
North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Cutting-Edge Market Trends Are Expected to Drive the Prenatal Testing & Newborn Screening Market’s Growth?
Leading corporations in the prenatal testing & newborn screening sector are introducing innovative schemes that leverage rWGS (rapid Whole Genome Sequencing) technology. This technology can quickly and precisely identify genetic disorders in newborns, allowing for timely intervention and diagnosis, thus, improving health outcomes. Unlike conventional genetic testing methods that focus on particular genes or regions, rWGS technology sequences an individual’s entire genome, capturing all DNA to identify disease-related genetic variations. For example, Rady Children’s Institute for Genomic Medicine, an American company, launched a new program titled BeginNGS in June 2022. The agenda aims to identify and diagnose around 400 genetic disorders that have available treatment options prior to symptom appearance. With an aim to broaden its testing capabilities to include around 1,000 disorders, BeginNGS is refining genomic sequencing methods. The ultimate aspiration is to conduct tests for approximately 3.7 million newborns on a annual basis, aiming to make it a customary procedure at hospitals across the country.
View the full report here:
How Is the Prenatal Testing & Newborn Screening Market Conceptually Defined?
Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
